New Vaccine For Two Deadly Cancers Shows Promise in Clinical Trial : ScienceAlert
Notoriously hard to treat, pancreatic and colorectal cancers each have high recurrence rates in the years following treatment.A new 'off-the-shelf'...
Notoriously hard to treat, pancreatic and colorectal cancers each have high recurrence rates in the years following treatment.A new 'off-the-shelf'...
Ogrodnik, M. et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell 187, 4150–4175 (2024).CAS PubMed PubMed...
At the time when patients with lupus, or systemic lupus erythematosus (SLE), are diagnosed, approximately 15% to 30% will already...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate...
For the first time, researchers have transplanted gene-edited donor islet cells that secrete insulin in a person with type 1...
Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave...